SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Insmed Inc. (INSM)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
136 17 0 INSM
Emcee:  SI (no user) Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11Insmed Incorporated and Oxagen Limited Form Partnership to Create a Genetic Studmopgcw-2/18/2002
10Insmed Incorporated Reports Fourth Quarter and Year-end Financial Results RICHMOSemiBull-1/30/2002
9Insmed Reports Positive Effects of SomatoKine in Subjects With Type 2 Diabetes SemiBull-1/8/2002
8Robertson Stephenson presentation: webevents.broadcast.commopgcw-11/30/2001
7Insiders buying: biz.yahoo.commopgcw-10/11/2001
6CFO Interview: twst.com MICHAEL BAER - INSMED INCORPORATED (INSM) CEO Intervimopgcw-10/1/2001
538.204.37.95 Abstract #: 448-P Abstract Type: Poster: Clinical Diabetmopgcw-9/6/2001
4February 27, 2001 INSMED INCORPORATED ANNOUNCES POSITIVE RESULTS FOR TWO KEY PHmopgcw-9/6/2001
3March 20, 2001 INSMED ANNOUNCES POSITIVE SOMATOKINE® DATA IN PATIENTS WITHmopgcw-9/6/2001
2The Combination of Insulin-Like Growth Factor I and Insulin-Like Growth Factor-Bmopgcw-9/6/2001
1April 29th, 1999 Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polmopgcw-9/6/2001
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News